Kinnate Biopharma Inc.

NASDAQ: KNTE · Real-Time Price · USD
2.65
-0.01 (-0.38%)
At close: Apr 02, 2024, 10:00 PM

Kinnate Biopharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.98 -2.36 -8.64
PEG Ratio
0.15 -0.09 -0.06
PS Ratio
n/a n/a n/a
PB Ratio
0.69 1.20 2.42
P/FCF Ratio
-1.1 -2.93 -10.76
P/OCF Ratio
-1.1 -3.02 -10.87
OCF/S Ratio
n/a n/a n/a
Debt / Equity Ratio
0.02 0.02 n/a
Quick Ratio
13.19 13.45 20.88
Current Ratio
13.19 13.45 20.88
Asset Turnover
n/a n/a n/a
Interest Coverage
n/a n/a n/a
Return on Equity
-0.71 -0.51 -0.28
Return on Assets
-0.65 -0.41 -0.24
Return on Invested Capital
-0.73 -0.44 -0.25
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a n/a
Net Profit Margin
n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a
Operating Profit Margin
n/a n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a n/a n/a